Prosecution Insights
Last updated: November 04, 2026

Alpine Pet Opco LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Alpine Pet Opco LLC is currently managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to a distinct examiner and a distinct art unit, creating a highly centralized prosecution environment. With only one active case, the company can focus its legal resources on a single set of patentability issues.

The busiest examiner, PRAGANI, RAJAN, is responsible for the 1 pending office action. Because this examiner is the sole official reviewing the company's current applications, their specific interpretation of the law will determine the immediate success of the portfolio. The lack of examiner diversity means there are no other pending matters to offset a potential rejection from this individual.

Operating within a single art unit allows the applicant to tailor their arguments to the specific culture and guidelines of that unit. Practitioners should prioritize understanding the previous rulings and preferences of PRAGANI, RAJAN to navigate the prosecution process effectively. This concentrated focus minimizes administrative complexity while emphasizing the importance of this individual examiner's perspective.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PRAGANI, RAJAN 1 53.1% +69.8%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18848152 EDIBLE SOFT DENTAL CHEW AND METHODS OF USING THE SAME PRAGANI, RAJAN —

Top Art Units

Art UnitApps
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18848152 EDIBLE SOFT DENTAL CHEW AND METHODS OF USING THE SAME PRAGANI, RAJAN 1614 §103§112DP Non-Final OA — Pending Sep 18, 2024

Managing Alpine Pet Opco LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Alpine Pet Opco LLC have?

Alpine Pet Opco LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Alpine Pet Opco LLC applications?

Rajan Pragani has the most, with 1 of Alpine Pet Opco LLC's pending office actions.

What technology area are Alpine Pet Opco LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month